Press Releases

Macular Degeneration Research

The FDA has approved a new treatment for “wet” AMD.  Known as Vabysmo™, it can extend time between treatments for up to four months.

Feb 1, 2022
Alzheimer's Disease Research

A pending Medicare decision could create a “chilling effect” on research.

Jan 12, 2022
Alzheimer's Disease Research

BrightFocus Foundation, a nonprofit organization funding scientific research to end diseases of mind and sight, Alzheimer’s, macular degeneration and glaucoma, announced a special program, Brain Info Live: A Fireside Chat for Caregivers with Richard Lui.

Dec 6, 2021